Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
19.95
-0.55 (-2.68%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Prenetics Global Revenue
In the year 2025, Prenetics Global had annual revenue of $92.39M with 201.72% growth. Prenetics Global had revenue of $36.56M in the quarter ending December 31, 2025, with 248.57% growth.
Revenue (ttm)
$92.39M
Revenue Growth
+201.72%
P/S Ratio
3.63
Revenue / Employee
$324,175
Employees
285
Market Cap
335.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 92.39M | 61.77M | 201.72% |
| Dec 31, 2024 | 30.62M | 8.88M | 40.83% |
| Dec 31, 2023 | 21.74M | 8.58M | 65.17% |
| Dec 31, 2022 | 13.16M | 631.26K | 5.04% |
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 824.50M |
| NeoGenomics | 727.33M |
| OPKO Health | 606.88M |
| CareDx | 379.81M |
| Castle Biosciences | 344.23M |
| Fulgent Genetics | 322.67M |
| MDxHealth | 107.88M |
| FONAR | 106.03M |
PRE News
- 6 days ago - Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation - GlobeNewsWire
- 5 weeks ago - Prenetics Global Limited (PRE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Top Small-Cap Stocks Leading The Market Rotation - Seeking Alpha
- 5 weeks ago - Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity - GlobeNewsWire
- 5 weeks ago - Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY - GlobeNewsWire
- 5 weeks ago - Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors - GlobeNewsWire
- 6 weeks ago - Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder - GlobeNewsWire
- 2 months ago - Prenetics: Strong Liquidity And Rapidly Rising Revenue - Seeking Alpha